ANAT2341 Lab 6: Difference between revisions
No edit summary |
m (→References) |
||
(One intermediate revision by the same user not shown) | |||
Line 21: | Line 21: | ||
|} | |} | ||
[[Media:Slides_for_Dr_K_Walters_embryology_lecture_2018_31.8.18.pdf|Walters Lecture Slides]] | [[Media:Slides_for_Dr_K_Walters_embryology_lecture_2018_31.8.18.pdf|'''Walters Lecture Slides''']] | ||
==An Introduction to Polycystic Ovary Syndrome (PCOS)== | ==An Introduction to Polycystic Ovary Syndrome (PCOS)== | ||
Line 43: | Line 43: | ||
'''Dihydrotestosterone''' - The hormonally active form of testosterone (male sex hormone) produced by enzyme (5-alpha reductase) conversion. In the male embryo, this can occur in the genital skin which then supports external genital development. In the adult, this conversion occurs in a number of different tissues. A known treatment for prostate cancer include 5-alpha reductase inhibitors. | '''Dihydrotestosterone''' - The hormonally active form of testosterone (male sex hormone) produced by enzyme (5-alpha reductase) conversion. In the male embryo, this can occur in the genital skin which then supports external genital development. In the adult, this conversion occurs in a number of different tissues. A known treatment for prostate cancer include 5-alpha reductase inhibitors. | ||
|} | |} | ||
==Role of Androgens in the Ovary== | |||
{{#pmid:28687450}} | |||
:"It has been well established for decades that androgens, namely {{testosterone}} (T) plays an important role in female reproductive physiology as the precursor for oestradiol (E2). However, in the last decade a direct role for androgens, acting via the androgen receptor (AR), in female reproductive function has been confirmed. Deciphering the specific roles of androgens in ovarian function has been hindered as complete androgen resistant females cannot be generated by natural breeding. In addition, androgens can be converted into estrogens which has caused confusion when interpreting findings from pharmacological studies, as observed effects could have been mediated via the AR or estrogen receptor. The creation and analysis of genetic {{mouse}} models with global and cell-specific disruption of the Ar gene, the sole mediator of pure androgenic action, has now allowed the elucidation of a role for AR-mediated androgen actions in the regulation of normal and pathological ovarian function. This review aims to summarize findings from clinical, animal, pharmacological and novel genetic AR mouse models to provide an understanding of the important roles androgens play in the {{ovary}}, as well as providing insights into the human implications of these roles." | |||
==References== | ==References== |
Revision as of 10:37, 16 July 2019
1. QUIZ
2. Guest Lecturer - Dr Kirsty Walters
An Introduction to Polycystic Ovary Syndrome (PCOS)
<html5media width="600" height="400">https://www.youtube.com/embed/NhyYZCBq5A8</html5media>
Polycystic Ovary Syndrome Mouse Model
Caldwell ASL, Edwards MC, Desai R, Jimenez M, Gilchrist RB, Handelsman DJ & Walters KA. (2017). Neuroendocrine androgen action is a key extraovarian mediator in the development of polycystic ovary syndrome. Proc. Natl. Acad. Sci. U.S.A. , 114, E3334-E3343. PMID: 28320971 DOI.
Role of Androgens in the Ovary
Walters KA & Handelsman DJ. (2017). Role of androgens in the ovary. Mol. Cell. Endocrinol. , , . PMID: 28687450 DOI.
- "It has been well established for decades that androgens, namely testosterone (T) plays an important role in female reproductive physiology as the precursor for oestradiol (E2). However, in the last decade a direct role for androgens, acting via the androgen receptor (AR), in female reproductive function has been confirmed. Deciphering the specific roles of androgens in ovarian function has been hindered as complete androgen resistant females cannot be generated by natural breeding. In addition, androgens can be converted into estrogens which has caused confusion when interpreting findings from pharmacological studies, as observed effects could have been mediated via the AR or estrogen receptor. The creation and analysis of genetic mouse models with global and cell-specific disruption of the Ar gene, the sole mediator of pure androgenic action, has now allowed the elucidation of a role for AR-mediated androgen actions in the regulation of normal and pathological ovarian function. This review aims to summarize findings from clinical, animal, pharmacological and novel genetic AR mouse models to provide an understanding of the important roles androgens play in the ovary, as well as providing insights into the human implications of these roles."
References
Walters KA, Edwards MC, Tesic D, Caldwell ASL, Jimenez M, Smith JT & Handelsman DJ. (2018). The Role of Central Androgen Receptor Actions in Regulating the Hypothalamic-Pituitary-Ovarian Axis. Neuroendocrinology , 106, 389-400. PMID: 29635226 DOI.
Leloup-Hatey J, Baloche S & Jolivet-Jaudet G. (1988). [Changes in corticosterone and aldosterone concentrations in various tissues of Xenopus laevis tadpoles during the metamorphosis]. C. R. Seances Soc. Biol. Fil. , 182, 354-60. PMID: 2977958 1
Bertoldo MJ, Walters KA, Ledger WL, Gilchrist RB, Mermillod P & Locatelli Y. (2018). In-vitro regulation of primordial follicle activation: challenges for fertility preservation strategies. Reprod. Biomed. Online , , . PMID: 29503209 DOI.
Upton DH, Walters KA, McTavish KJ, Holt J, Handelsman DJ & Allan CM. (2018). Reproductive failure in mice expressing transgenic follicle-stimulating hormone is not caused by loss of oocyte quality. Biol. Reprod. , 98, 491-500. PMID: 29365049 DOI.
Walters KA & Handelsman DJ. (2017). Role of androgens in the ovary. Mol. Cell. Endocrinol. , , . PMID: 28687450 DOI.
Search PubMed: Walters KA